Loading...
Loading...
Among the 5 tracked institutional investors we monitor, TRAW (TRAWS PHARMA INC) is held with a combined value of $744.36K across 853,004 shares. The largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with a position worth $615.61K. 2 funds reduced their position.
Total Institutional Value
$744.36K
Total Shares Held
853,004
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $615.61K | 0.00% | - |
| 2 | VANGUARD GROUP INC | $98.60K | 0.00% | - |
| 3 | STATE STREET CORP | $21.76K | 0.00% | - |
| 4 | BlackRock, Inc. | $8.38K | 0.00% | -0.2% |
| 5 | FMR LLC | $2 | 0.00% | -91.3% |
As of the latest SEC 13F filings, ADAGE CAPITAL PARTNERS GP, L.L.C. is the largest institutional holder of TRAW with a position worth $615.61K, representing 0.00% of their portfolio. In total, 5 institutional investors hold TRAW with a combined value of $744.36K.
Institutional investors hold $744.36K worth of TRAW stock across 5 positions. The largest institutional holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with $615.61K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TRAW, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TRAW positions.
| 2026-08-14 |
| 9.9% | 2026-08-14 |
| 4.8% | 2026-08-12 |
SEC Schedule 13D (activist) and 13G (passive) filings for TRAW. Filed when an investor acquires 5%+ ownership.
Last Close
$0.38
2026-10-21
YTD
-71.7%
0% of 52-week range